Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | CNOT7 | Q9UIV1 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24603682 | 0.99 | TDP1 (0.47) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL20964368 | 0.91 | ALDH1A1 (0.55) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL24603666 | 0.90 | ALDH1A1 (0.51) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL24603782 | 0.89 | CYP1B1 (0.56) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL20964322 | 0.89 | STAT3 (0.47) | MAPTALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL24704063 | 0.89 | ALDH1A1 (0.55) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL22605887 | 0.83 | MEN1 (0.51) | MAPTALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL24603683 | 0.80 | RAB9A (0.45) | MAPTALDH1A1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL25548743 | 0.79 | CA12 (0.43) | CYP1B1MAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL20964369 | 0.79 | CYP1B1 (0.45) | CYP1B1MAPTALDH1A1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025901-A1 | METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025901-A1 | METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND | INF2, NISCH, ITPA | CYP1B1 206/4885MAPT 3725/4885ALDH1A1 2802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.